Bristol Myers Squibb, GRYT Health double down on diversity in cancer

GRYT Health and Bristol Myers Squibb are doubling down on their four-part series Diversity in Oncology's interactive sessions with the third session, “Improving Representation of Diversity in Clinical Trials Through Academia and Community Collaboration.”